These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 22836914)

  • 1. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
    Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
    Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
    DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
    J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed choice vs. no choice in colorectal cancer screening tests: a prospective cohort study in real-life screening practice.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SC; Ng SS; Sung JJ
    Am J Gastroenterol; 2014 Jul; 109(7):1072-9. PubMed ID: 24935273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician counseling for colorectal cancer screening: impact on patient attitudes, beliefs, and behavior.
    Fenton JJ; Jerant AF; von Friederichs-Fitzwater MM; Tancredi DJ; Franks P
    J Am Board Fam Med; 2011; 24(6):673-81. PubMed ID: 22086810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
    Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening among Mexican Americans at a community clinic.
    Yepes-Rios M; Reimann JO; Talavera AC; Ruiz de Esparza A; Talavera GA
    Am J Prev Med; 2006 Mar; 30(3):204-10. PubMed ID: 16476635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
    Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
    Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening among Latinos from U.S. cities along the Texas-Mexico border.
    Fernandez ME; Wippold R; Torres-Vigil I; Byrd T; Freeberg D; Bains Y; Guajardo J; Coughlin SS; Vernon SW
    Cancer Causes Control; 2008 Mar; 19(2):195-206. PubMed ID: 18038186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening attitudes and practices preferences for decision making.
    Messina CR; Lane DS; Grimson R
    Am J Prev Med; 2005 Jun; 28(5):439-46. PubMed ID: 15894147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored navigation in colorectal cancer screening.
    Myers RE; Hyslop T; Sifri R; Bittner-Fagan H; Katurakes NC; Cocroft J; Dicarlo M; Wolf T
    Med Care; 2008 Sep; 46(9 Suppl 1):S123-31. PubMed ID: 18725824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening: physician attitudes and practices.
    Taylor ML; Anderson R
    WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intervention to change the approach to colorectal cancer screening in primary care.
    Spruce LR; Sanford JT
    J Am Acad Nurse Pract; 2012 Apr; 24(4):167-74. PubMed ID: 22486831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equity and practice issues in colorectal cancer screening: Mixed-methods study.
    Buchman S; Rozmovits L; Glazier RH
    Can Fam Physician; 2016 Apr; 62(4):e186-93. PubMed ID: 27618142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.